Previous Section
Clinical Trials
1. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
- Author
- Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
- Institution
- Veterans Affairs Palo Alto Health Care Systems and Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, California 94304, USA. rjamison@stanford.edu
- Journal
- JAMA. 2007 Sep 12;298(10):1163-70.
- Abstract URL
- Click here to view abstract
2. Clinical effects of combined therapy with peritoneal dialysis and hemodialysis.
- Author
- Kawanishi H; Moriishi M;
- Institution
- Tsuchiya General Hospital, Hiroshima, Japan. h-kawanishi@tsuchiya-hp.jp
- Journal
- Perit Dial Int. 2007 Jun;27 Suppl 2:S126-9.
- Abstract URL
- Click here to view abstract
3. Eprodisate for the treatment of renal disease in AA amyloidosis.
- Author
- Dember LM; Hawkins PN; Hazenberg BP; Gorevic PD; Merlini G; Butrimiene I; Livneh A; Lesnyak O; Puechal X; Lachmann HJ; Obici L; Balshaw R; Garceau D; Hauck W; Skinner M;
- Institution
- Boston University School of Medicine, Boston, MA 02118, USA. ldember@bu.edu
- Journal
- N Engl J Med. 2007 Jun 7;356(23):2349-60.
- Abstract URL
- Click here to view abstract
4. Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.
- Author
- Plantinga LC; Fink NE; Levin NW; Jaar BG; Coresh J; Levey AS; Klag MJ; Powe NR;
- Institution
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- Journal
- Am J Kidney Dis. 2007 Jun;49(6):831-40.
- Abstract URL
- Click here to view abstract
5. Vitamins are associated with survival in patients with end-stage renal disease: a 4-year prospective study.
- Author
- Domrose U; Heinz J; Westphal S; Luley C; Neumann KH; Dierkes J;
- Institution
- Division of Nephrology, University Hospital Magdeburg, Germany.
- Journal
- Clin Nephrol. 2007 Apr;67(4):221-9.
- Abstract URL
- Click here to view abstract
6. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study.
- Author
- Nanayakkara PW; van Guldener C; ter Wee PM; Scheffer PG; van Ittersum FJ; Twisk JW; Teerlink T; van Dorp W; Stehouwer CD;
- Institution
- Department of Internal Medicine, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, and Amphia Hospital, Breda, the Netherlands. p.nanayakkara@vumc.nl
- Journal
- Arch Intern Med. 2007 Jun 25;167(12):1262-70.
- Abstract URL
- Click here to view abstract
7. The Lipid lowering and Onset of Renal Disease (LORD) Trial: a randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progression of kidney disease.
- Author
- Fassett RG; Ball MJ; Robertson IK; Geraghty DP; Coombes JS;
- Institution
- Renal Research Tasmania, Launceston General Hospital, Charles St,, Launceston, Tasmania, 7005, Australia. rob.fassett@dhhs.tas.gov.au
- Journal
- BMC Nephrol. 2008 Mar 18;9:4.
- Abstract URL
- Click here to view abstract
8. Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness.
- Author
- Chan L; Greenstein S; Hardy MA; Hartmann E; Bunnapradist S; Cibrik D; Shaw LM; Munir L; Ulbricht B; Cooper M;
- Institution
- Health Sciences Center, University of Colorado, Denver, CO 80262, USA. larry.chan@uchsc.edu
- Journal
- Transplantation. 2008 Mar 27;85(6):821-6.
- Abstract URL
- Click here to view abstract
9. The effect of increasing dialysis dose in overweight hemodialysis patients on quality of life: a 6-week randomized crossover trial.
- Author
- Wang W; Tonelli M; Hemmelgarn B; Gao S; Johnson JA; Taub K; Manns B;
- Institution
- Department of Medicine, Division of Nephrology, University of Calgary, Foothills Medical Center, Calgary, Alberta, Canada.
- Journal
- Am J Kidney Dis. 2008 May;51(5):796-803. Epub 2008 Apr 2.
- Abstract URL
- Click here to view abstract
10. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
- Author
- Shepherd J; Kastelein JJ; Bittner V; Deedwania P; Breazna A; Dobson S; Wilson DJ; Zuckerman A; Wenger NK;
- Institution
- University of Glasgow, Glasgow, United Kingdom. jshepherd@gri-biochem.org.uk
- Journal
- J Am Coll Cardiol. 2008 Apr 15;51(15):1448-54.
- Abstract URL
- Click here to view abstract
Next: Kidney Transplantation
